3-15601668-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001407365.1(BTD):c.-17+21G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0928 in 1,553,726 control chromosomes in the GnomAD database, including 8,890 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 1012 hom., cov: 32)
Exomes 𝑓: 0.092 ( 7878 hom. )
Consequence
BTD
NM_001407365.1 intron
NM_001407365.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.96
Genes affected
HACL1 (HGNC:17856): (2-hydroxyacyl-CoA lyase 1) Enables several functions, including 2-hydroxy-3-methylhexadecanoyl-CoA lyase activity; ATP binding activity; and cation binding activity. Involved in fatty acid alpha-oxidation; phytanic acid metabolic process; and protein targeting to peroxisome. Located in nucleoplasm and peroxisome. [provided by Alliance of Genome Resources, Apr 2022]
BTD (HGNC:1122): (biotinidase) The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 3-15601668-G-A is Benign according to our data. Variant chr3-15601668-G-A is described in ClinVar as [Benign]. Clinvar id is 1221031.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.359 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTD | NM_001407365.1 | c.-17+21G>A | intron_variant | NP_001394294.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HACL1 | ENST00000628377.2 | c.-205C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/16 | 5 | ENSP00000486684.1 | ||||
BTD | ENST00000449107 | c.-119G>A | 5_prime_UTR_variant | 1/4 | 2 | ENSP00000388212.2 | ||||
HACL1 | ENST00000628377.2 | c.-205C>T | 5_prime_UTR_variant | 1/16 | 5 | ENSP00000486684.1 | ||||
BTD | ENST00000427382.2 | c.-17+21G>A | intron_variant | 4 | ENSP00000397113.2 |
Frequencies
GnomAD3 genomes AF: 0.0999 AC: 15199AN: 152148Hom.: 1011 Cov.: 32
GnomAD3 genomes
AF:
AC:
15199
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0920 AC: 128915AN: 1401460Hom.: 7878 Cov.: 35 AF XY: 0.0935 AC XY: 64646AN XY: 691646
GnomAD4 exome
AF:
AC:
128915
AN:
1401460
Hom.:
Cov.:
35
AF XY:
AC XY:
64646
AN XY:
691646
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0998 AC: 15202AN: 152266Hom.: 1012 Cov.: 32 AF XY: 0.101 AC XY: 7533AN XY: 74464
GnomAD4 genome
AF:
AC:
15202
AN:
152266
Hom.:
Cov.:
32
AF XY:
AC XY:
7533
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
810
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 27, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at